No Evidence for Increased Brain Tumour Incidence in the Swedish National Cancer Register Between Years 1980-2012.


Journal

Anticancer research
ISSN: 1791-7530
Titre abrégé: Anticancer Res
Pays: Greece
ID NLM: 8102988

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 06 12 2018
revised: 14 12 2018
accepted: 18 12 2018
entrez: 4 2 2019
pubmed: 4 2 2019
medline: 21 3 2019
Statut: ppublish

Résumé

The main objective of this study was to evaluate if there was an increased incidence of brain tumours between years 1980-2012, a time period when mobile phone usage has increased substantially. From the Swedish Cancer Registry, cases of meningiomas, low-grade gliomas (LGG) and high-grade gliomas (HGG) were identified in patients between 1980-2012. Direct age-standardised incidence rates were used to calculate incidence trends over time. A total of 13,441 cases of meningiomas, 12,259 cases of high-grade gliomas and 4,555 cases of LGG were reported to the register during the study period. The results suggest that there may be a negative development in the trend for LGG of -0,016 cases per 100,000 and year, corresponding to a mean reduction of approximately 1% per year. The present study was not able to demonstrate an increased incidence of glioma during the past 30 years in Sweden.

Sections du résumé

BACKGROUND/AIM OBJECTIVE
The main objective of this study was to evaluate if there was an increased incidence of brain tumours between years 1980-2012, a time period when mobile phone usage has increased substantially.
MATERIALS AND METHODS METHODS
From the Swedish Cancer Registry, cases of meningiomas, low-grade gliomas (LGG) and high-grade gliomas (HGG) were identified in patients between 1980-2012. Direct age-standardised incidence rates were used to calculate incidence trends over time.
RESULTS RESULTS
A total of 13,441 cases of meningiomas, 12,259 cases of high-grade gliomas and 4,555 cases of LGG were reported to the register during the study period. The results suggest that there may be a negative development in the trend for LGG of -0,016 cases per 100,000 and year, corresponding to a mean reduction of approximately 1% per year.
CONCLUSION CONCLUSIONS
The present study was not able to demonstrate an increased incidence of glioma during the past 30 years in Sweden.

Identifiants

pubmed: 30711958
pii: 39/2/791
doi: 10.21873/anticanres.13176
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

791-796

Informations de copyright

Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Auteurs

Jonas Nilsson (J)

Center for Research and Development, Uppsala University/County Council of Gävleborg, Gävle Hospital, Gävle, Sweden.
Department of Radiation Sciences and Oncology, Umeå University, Umeå, Sweden.
Department of Radiology, Gävle Hospital, Gävle, Sweden.

Jacob Järås (J)

Regional Cancer Center Stockholm-Gotland, Stockholm, Sweden.

Roger Henriksson (R)

Department of Radiation Sciences and Oncology, Umeå University, Umeå, Sweden.
Regional Cancer Center Stockholm-Gotland, Stockholm, Sweden.

Georg Holgersson (G)

Department of Immunology, Genetics and Pathology, Uppsala, Sweden.

Stefan Bergström (S)

Center for Research and Development, Uppsala University/County Council of Gävleborg, Gävle Hospital, Gävle, Sweden.
Department of Oncology, Gävle Hospital, Gävle, Sweden.

Jimmy Estenberg (J)

Swedish Radiation Safety Authority, Stockholm, Sweden.

Torsten Augustsson (T)

Swedish Radiation Safety Authority, Stockholm, Sweden.

Michael Bergqvist (M)

Center for Research and Development, Uppsala University/County Council of Gävleborg, Gävle Hospital, Gävle, Sweden michael.bergqvist@regiongavleborg.se.
Department of Radiation Sciences and Oncology, Umeå University, Umeå, Sweden.
Department of Oncology, Gävle Hospital, Gävle, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH